During the past decade, Zentrum für Rhinologie und Allergologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zentrum für Rhinologie und Allergologie" #1 sponsor was "HAL Allergy" with 2 trials, followed by "Leti Pharma GmbH" with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored, "Biomay AG" with 1 trials sponsored and "Roxall Medizin" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zentrum für Rhinologie und Allergologie" #1 collaborator was "Labor Dr. Spranger (Central lab)" with 1 trials as a collaborator, "Laboratorios LETI SL (Study Medication)" with 1 trials as a collaborator and "Pierrel Research Europe GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Zentrum für Rhinologie und Allergologie" are "Allergic Rhinitis" (3 trials), "Allergic Rhinoconjunctivitis" (3 trials), "Allergic Rhinitis and/or Rhinoconjunctivitis +- Asthma" (1 trials), "Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma" (1 trials) and "Dose-Finding Study" (1 trials). Many other conditions were trialed in "Zentrum für Rhinologie und Allergologie" in a lesser frequency.

Most popular intervention types in "Zentrum für Rhinologie und Allergologie" are "Biological" (5 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Allergoid, allergenic extract of 100% Birch" (1 trials), "BM32" (1 trials), "Depigoid Phleum" (1 trials) and "Grazax + Aerius" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zentrum für Rhinologie und Allergologie" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Zentrum für Rhinologie und Allergologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Zentrum für Rhinologie und Allergologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zentrum für Rhinologie und Allergologie, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".